-
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody for MAVS
2026-08-16
Translate ASB3–MAVS biology into sharper immunofluorescence, western blot, IHC, and flow cytometry readouts with a far-red Cy5 secondary. This workflow emphasizes assay controls, storage discipline, and practical troubleshooting for low-abundance antiviral signaling proteins.
-
Intestinal TM6SF2 Protects Against MASH
2026-08-15
This Nature Metabolism study identifies intestinal TM6SF2 as a protective regulator of the gut–liver axis, linking epithelial lipid handling to barrier integrity, microbial dysbiosis, lysophosphatidic acid signaling and hepatic inflammation. Conditional mouse genetics, fecal transplantation, cohousing and pharmacological validation establish a causal framework for understanding how intestinal TM6SF2 deficiency drives MASH.
-
Novobiocin Hybrids Against Toxoplasma gondii
2026-08-14
A 2024 Acta Parasitologica study evaluated 12 quinolone–coumarin hybrids derived from fluoroquinolones and Novobiocin against Toxoplasma gondii. QC1, QC3, QC6, and the parent compound showed favorable antiparasitic selectivity in cell-based assays, supporting further lead optimization while remaining preliminary because the evidence is entirely in vitro.
-
Medium-Chain TAGs as Adjuvants in Mouse CHS
2026-08-14
The reference study shows that triacylglycerol side-chain length influences adjuvant activity in a mouse FITC-induced contact hypersensitivity model: C4, C6, C8, and C10 compounds enhanced sensitization, whereas C12 trilaurin did not. Mechanistic analysis linked the active C6–C10 compounds with increased migration of FITC-presenting CD11c+ dendritic cells to draining lymph nodes, defining a chain-length-dependent immunological boundary.
-
Tubastatin A: HDAC6 Inhibition in Practice
2026-08-13
Tubastatin A is a selective HDAC6 inhibitor for connecting α-tubulin acetylation with cancer biology, inflammation, neuroprotection, and tissue injury. This workflow-focused guide translates cellular mechanism into practical dosing, assay design, and troubleshooting, including lessons from a porcine cardiac-arrest study.
-
NF 340: Selective P2Y11 Antagonist Guide
2026-08-13
NF 340 is a selective P2Y11 antagonist for studying purinergic GPCR signaling pathway biology. In a breast cancer study, NF 340 reversed QPRT-associated invasiveness and myosin light-chain phosphorylation, supporting its use as a mechanistic research probe rather than a therapeutic product.
-
NAD+ Workflows for Stress-Response Assays
2026-08-12
Build sharper autophagy and DNA-damage experiments by pairing NAD+ handling with caspase, PARP1, and H2AX readouts. This workflow distinguishes metabolic support from causal pathway effects while providing practical preparation, dosing, and troubleshooting guidance.
-
nor-NOHA Acetate: Arginine Metabolism Meets AML Immunity
2026-08-12
nor-NOHA acetate offers a mechanistically defined way to interrogate arginase activity, nitric oxide biology, tumor-cell behavior, and endothelial signaling. When placed alongside recent evidence that CD36-driven lipid sensing enables immune escape in AML, it becomes a useful hypothesis-testing tool for translational immunometabolism research—not a substitute for clinical validation.
-
GDC-0068: Mapping Akt–mTOR Spatial Signaling
2026-08-11
GDC-0068, also known as RG7440, offers a pharmacological route to interrogate pan-AKT control of mTORC1, tumor growth, and therapy-relevant phenotypes. This thought-leadership guide connects emerging evidence on nuclear mTORC1 with practical experimental design and translational decision-making.
-
Sulfaphenazole: CYP2C9 Inhibition in Tissue Repair
2026-08-11
Sulfaphenazole connects precise CYP2C9 inhibition with practical workflows for drug metabolism, vascular endothelial function, oxidative stress, and antibacterial research. This guide translates its biochemical potency and preclinical wound-healing evidence into assay-ready setup, dosing, controls, and troubleshooting decisions.
-
Stattic Workflows for STAT3 Inhibition
2026-08-10
Stattic provides a practical way to connect STAT3 pathway disruption with proliferation, apoptosis, and radiation-response measurements in HNSCC models. This guide combines dose-finding, mechanistic validation, fluorescence-polarization controls, and troubleshooting strategies for more interpretable cancer biology experiments.
-
Polybrene for Viral Transduction Workflows
2026-08-09
Polybrene improves lentiviral and retroviral delivery by reducing electrostatic barriers at the cell surface, while also supporting difficult lipid-mediated DNA transfection. This practical guide connects concentration screening, exposure control, and construct-delivery workflows to mutant-p53 assays inspired by a recent TRAP-1 study.
-
Guanabenz Acetate in GPCR Stress-Response Assays
2026-08-08
Guanabenz Acetate provides a selective α2-adrenergic receptor agonist framework for dissecting GPCR signaling alongside stress-response biology. This article develops a compartment-aware assay strategy that distinguishes receptor-driven effects from GADD34 and stress-foci mechanisms reported in SARS-CoV-2 research.
-
L. gasseri, NR1I3, and E-Cadherin in Colitis
2026-08-07
Qian et al. identify an NR1I3–CDH1/E-cadherin pathway through which Lactobacillus gasseri ATCC33323 protects the intestinal mucosal barrier in DSS-induced colitis. By combining probiotic intervention with intestinal E-cadherin semiknockdown and in vitro transcriptional studies, the work moves beyond phenotypic probiotic effects toward a testable molecular mechanism.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Usage
2026-08-07
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is designed to prevent protein degradation during extraction, especially in workflows sensitive to divalent cations. It is not suitable for protocols requiring metal chelation or for applications incompatible with DMSO.